Search research articles
Contact Us
Filters
Showing results (1081-1090 of 1,520) with videos related to
Page
of 152
Sort By:
Cancer
|
May 17, 2002
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist
Jame Abraham, Susan Bakke, Ann Rutt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 15, 1994
National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma
F J Sullivan, L L Herscher, J A Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers
Wyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
Cancer Research
|
December 20, 2007
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2
Christine E Horak, Arnulfo Mendoza, Eleazar Vega-Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas
Elizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report
J C Yang, S L Topalian, D Parkinson, et al.
Annals of Surgical Oncology
|
April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer
D N Danforth, J Zujewski, J O'Shaughnessy, et al.
Cancer
|
August 12, 2003
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial
Matthew M Poggi, David N Danforth, Linda C Sciuto, et al.
The American Surgeon
|
January 26, 2012
Dynamic changes in respiratory frequency/tidal volume may predict failures of ventilatory liberation in patients on prolonged mechanical ventilation and normal preliberation respiratory frequency/tidal volume values
Raeanna C Adams, Oliver L Gunter, Jonathan R Wisler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
S A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Page
of 152
Search research articles
Search
Showing results (1081-1090 of 1,520) with videos related to
Sort By:
Page
of 152
Cancer
|
May 17, 2002
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist
Jame Abraham, Susan Bakke, Ann Rutt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 15, 1994
National Cancer Institute (phase II) study of high-grade glioma treated with accelerated hyperfractionated radiation and iododeoxyuridine: results in anaplastic astrocytoma
F J Sullivan, L L Herscher, J A Cook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers
Wyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
Cancer Research
|
December 20, 2007
Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2
Christine E Horak, Arnulfo Mendoza, Eleazar Vega-Valle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 19, 2009
Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas
Elizabeth Fox, Brigitte C Widemann, Douglas S Hawkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: an interim report
J C Yang, S L Topalian, D Parkinson, et al.
Annals of Surgical Oncology
|
April 4, 1998
Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer
D N Danforth, J Zujewski, J O'Shaughnessy, et al.
Cancer
|
August 12, 2003
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial
Matthew M Poggi, David N Danforth, Linda C Sciuto, et al.
The American Surgeon
|
January 26, 2012
Dynamic changes in respiratory frequency/tidal volume may predict failures of ventilatory liberation in patients on prolonged mechanical ventilation and normal preliberation respiratory frequency/tidal volume values
Raeanna C Adams, Oliver L Gunter, Jonathan R Wisler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
S A Rosenberg, J C Yang, D J Schwartzentruber, et al.
Page
of 152